Marcus Björnsson, Ph.D.

Principal Consultant & Team Leader


  • Joined Pharmetheus in 2014, actively working in client projects and serving as Project Portfolio Team Leader
  • Expertise includes pharmacometrics, clinical pharmacology, and pediatrics in therapeutic areas such as neuroscience and orphan indications
  • Previously worked as Neuroscience Therapy Area Pharmacometrics Expert at AstraZeneca R&D, Sweden, where he had strategic and scientific accountability for pharmacometric activities within the neuroscience therapy area, as Clinical Pharmacokineticist, Senior Research Scientist, and Senior Pharmacometrician at AstraZeneca R&D, Sweden, and Research Scientist at Astra Pain Control, Sweden
  • M.Sc. in Pharmaceutical Sciences (1999) and Ph.D. in Pharmacokinetics and Drug Therapy (2013) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorderDevelopment of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasmaPopulation Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use DisorderA Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers